Houston Methodist 4th Annual Bradley Z. Naifeh Amyloidosis Conference 2026

Event starts: 05/09/2026 – 8:00am CDT

Amyloidosis is an underrecognized condition because it has historically been misconceived to be a rare disease and presents in a myriad of clinical situations in a subtle manner. Recent advances in therapeutics have made it imperative that this condition is recognized and categorized appropriately in a timely manner so that individuals can get access to appropriate care. Due to a systemic nature of amyloid, various subspecialities are on the fore front of battling this disease. The goal of the Conference is to create a faculty panel from various disciplines to engage in the mission to promote awareness and educate attendees on Amyloidosis in a comprehensive manner.

Target Audience

Cardiologists, hematologists, neurologists, nephrologists, pulmonologists, hepatologists, nurse practitioners, nurses, social workers, transplant coordinators, and trainees in these subspecialities.

Learning Objectives

Upon completion of this course, the participant should be able to:

Identify and Diagnose Amyloidosis Early & Effectively
Apply Best Practices to Treat Amyloidosis
Utilize Appropriate Resources Available to Providers and Patients alike (non-profit institutions)
Describe the full influence of Amyloidosis: how it affects multiple specialties and all parts of the body, and how it becomes a fatal disease
List the multiple types of Amyloidosis

+ Topics:

01 Severe Aortic Regurgitation – Fully Endoscopic AVR via Lateral Minithoracotomy With 3D Visualization

02 Robotic Mitral Valve Surgery – Technical Pearls for Durable LAA Closure

03 Robotic Mitral Valve Repair – Building a Sustainable Program From Launch to Mastery

04 Direct Vision Minithoracotomy AVR – Step by Step

05 Democratizing Minimally Invasive Surgery – Where Do We Stand in 2026

06 Mini Maze Revisited – Innovation, Durability, and Its Role in Modern AF Surgery

07 Re-Evolution Talks – Moments with the Experts – Drs. Ramchandani and Velicki

08 Re-Evolution Talks – Moments with the Experts – Drs. Sarfaraz and Murtaza

09 Re-Evolution Talks – Moments with the Experts – Drs. Ramchandani and Knight

10 Artificial Intelligence in Cardiac Surgery – Building the AI-Enhanced Operating Room

11 Re-Evolution Talks – Moments with the Experts – Drs. Sarfaraz and Bisleri

12 Aortic Valve Disease in Younger Patients – Navigating TAVR-First vs SAVR-First Lifetime Management Strategies

13 Right Anterior Mini-Thoractomy AVR with Annular Enlargement

14 Minimally Invasive Cardiac Surgery and ERAS – Building a Standardized Pathway for Faster Recovery

15 When Not to Offer Minimally Invasive Mitral Valve Surgery – The Talk Nobody Gives

16 Emerging Transcatheter Heart Valve Technologies – Which TAVR, TMVR, and TR Devices Are Shaping Future Care

17 Robotic Aortic Valve Surgery – Where Roots Grow and Aneurysms Go

18 Re-Evolution Talks – Moments with the Experts – Drs. Ramchandani and Granov

19 Minimally Invasive Cardiac Surgery – Advanced Imaging for Preoperative Planning and Intraoperative Guidance

20 Mitral Re-Operation Strategies Through Minimally Invasive Access

21 2026 Re-Evolution Summit – Welcome and Course Vision

22 Structural Heart and Valve Surgery – Navigating the Transition to Total Endoscopic Cardiac Surgery

23 Minimally Invasive Cardiac Surgery Training – Building Skills Through Fellowships and International Mentorship

24 Endoscopic Mitral Repair – Where Do We Stand in 2026

25 AVR Disaster – Houston, We Have a Problem

26 When Should TAVI or SAVR Be First-Line Therapy for Aortic Valve Disease

27 Endoscopic Aortic Valve Replacement – Techniques, Outcomes, and Learning Curve

28 Failed MitraClip in Severe Mitral Regurgitation – Endoscopic Mitral Valve Replacement With Concomitant AF Ablation

29 Ascending Aorta and Hemiarch Through a Mini-Thoracotomy – Techniques, Outcomes, Learning Curve